PHARMACYCLICS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 3159
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
5587371 Texaphyrin-oligonucleotide conjugatesJun 02, 95Dec 24, 96[A61K, C07D]
5583220 Pyrole nitrogen-substituted texaphyrinsMay 24, 95Dec 10, 96[C07D]
5567687 Texaphyrins and uses thereofSep 21, 94Oct 22, 96[C07D]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
9062058 Pyrrolopyrimidine compounds as kinase inhibitorsWithdrawnNov 15, 13Jun 23, 15[A61K, A01N, C07D]
2014/0301,976 NOVEL HYDROXAMATES AS THERAPEUTIC AGENTSAbandonedJun 20, 14Oct 09, 14[A61K, C07D]
8663961 Inhibitors of Bruton's tyrosine kinaseWithdrawnMay 15, 12Mar 04, 14[A61K, A01N, C12N, C07D]
2013/0157,994 HIGH-PURITY TEXAPHYRIN METAL COMPLEXESAbandonedFeb 14, 13Jun 20, 13[A61K, C07F]
2012/0108,547 INHIBITORS OF TYROSINE KINASES AND USES THEREOFAbandonedDec 22, 11May 03, 12[A61K, A61P]
2012/0101,065 INHIBITORS OF TYROSINE KINASES AND USES THEREOFAbandonedDec 22, 11Apr 26, 12[A61K, A61P]
2012/0083,470 INHIBITORS OF TYROSINE KINASES AND USES THEREOFAbandonedOct 05, 11Apr 05, 12[A61K, A61P]
2012/0053,189 BTK INHIBITORS FOR THE TREATMENT OF IMMUNE MEDIATED CONDITIONSAbandonedJun 28, 11Mar 01, 12[A61K, C07D, A61P]
2007/0105,939 Mesylate salt of 5-(2-dimethylaminoethoxy)-1H-indole-2-carboxylic acid [3-(4-hydroxycarbamoylphenyl)prop-2-ynyl]amideAbandonedMay 24, 06May 10, 07[A61K, C07D]
2006/0292,072 Agents for neutron capture therapyAbandonedMay 19, 05Dec 28, 06[A61K, C07F, C07D]
2006/0128,638 Texaphyrin coordination compounds and uses thereofAbandonedFeb 06, 06Jun 15, 06[A61K, C07F]
2005/0261,171 Combination cancer therapyAbandonedOct 04, 04Nov 24, 05[A61K]
2005/0009,803 MESO-oxygenated texaphyrin analoguesAbandonedAug 04, 04Jan 13, 05[A61K, C07F]
2003/0153,493 Combination cancer therapyAbandonedDec 13, 02Aug 14, 03[A61K]
2003/0031,676 Conjugate compounds for treating atheroma and other diseasesAbandonedMay 30, 02Feb 13, 03[A61K, C07D, C07K]
2002/0115,649 Use of texaphyrins in macrophage-mediated diseaseAbandonedJan 05, 01Aug 22, 02[A61K, A61B]
6375930 Membrane incorporation of texaphyrinsExpiredNov 20, 97Apr 23, 02[A61B]
2002/0025,298 Use of texaphyrin in ocular diagnosis and therapyAbandonedAug 02, 01Feb 28, 02[A61K]
2001/0002,251 Intracellular sensitizers for sonodynamic therapyAbandonedJan 05, 01May 31, 01[A61K, A61B]
6207660 Texaphyrin conjugates and uses thereofExpiredJun 04, 99Mar 27, 01[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.